Bella Kaufman
NYU Langone Health(US)New York/New Jersey VA Health Care Network(US)
Publications by Year
Research Areas
BRCA gene mutations in cancer, Advanced Breast Cancer Therapies, PARP inhibition in cancer therapy, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research
Most-Cited Works
- → Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer(2006)3,443 cited
- → Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer(2019)2,462 cited
- → The human tumor microbiome is composed of tumor type–specific intracellular bacteria(2020)2,260 cited
- → 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited
- → Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation(2014)1,667 cited
- → Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer(2021)1,581 cited